Thus, it is highly probable that the deficit in synaptic strength and plasticity [46, 47], along with dysregulated BDNF–5-HT2A signaling, in ApoE4 carriers increases their risk of developing depression, which, in the presence of environmental stressors, can lead to the manifestation of clinical depression. Here, BDNF is linked to depressive symptom measurement.